Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Account Payables (2019 - 2025)

Historic Change in Account Payables for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $2.1 million.

  • Eton Pharmaceuticals' Change in Account Payables rose 28442.03% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 112996.81%. This contributed to the annual value of $2.3 million for FY2024, which is 427358.49% up from last year.
  • Eton Pharmaceuticals' Change in Account Payables amounted to $2.1 million in Q3 2025, which was up 28442.03% from $7.3 million recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Change in Account Payables high stood at $7.3 million for Q2 2025, and its period low was -$1.3 million during Q4 2021.
  • Over the past 5 years, Eton Pharmaceuticals' median Change in Account Payables value was $105000.0 (recorded in 2023), while the average stood at $625526.3.
  • Per our database at Business Quant, Eton Pharmaceuticals' Change in Account Payables tumbled by 103308.82% in 2021 and then surged by 568846.15% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Change in Account Payables (Quarter) stood at -$1.3 million in 2021, then soared by 156.11% to $712000.0 in 2022, then plummeted by 85.25% to $105000.0 in 2023, then skyrocketed by 1311.43% to $1.5 million in 2024, then skyrocketed by 43.18% to $2.1 million in 2025.
  • Its Change in Account Payables was $2.1 million in Q3 2025, compared to $7.3 million in Q2 2025 and $705000.0 in Q1 2025.